Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren’s syndrome diagnosis

References

• Vasaitis L. IgG4-related disease: a relatively new concept for clinicians. Eur J Intern Med 2016;27:1–9.
   PubMed Web of Science ®Google Scholar
• Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheumatol 2012;64:3061–7.
   PubMed Web of Science ®Google Scholar
• Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012;25:1181–92.
   PubMed Web of Science ®Google Scholar
• Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol 2011;23:108–13.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 2015;74:14–8.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol 2015;67:2466–75.
   PubMed Web of Science ®Google Scholar
• Brito-Zeron P, Ramos-Casals M, Bosch X, Stone JH. The clinical spectrum of IgG4-related disease. Autoimmun Rev 2014;13:1203–10.
   PubMed Web of Science ®Google Scholar
• Ekstrom Smedby K, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the interlymph consortium. Blood 2008;111:4029–38.
   PubMed Web of Science ®Google Scholar
• Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol 2008;32:1159–67.
   PubMed Web of Science ®Google Scholar
• Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H. Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells. J Clin Pathol 2010;63:1059–65.
   PubMed Web of Science ®Google Scholar
• Nakayama R, Matsumoto Y, Horiike S, Kobayashi S, Nakao R, Nagoshi H, et al. Close pathogenetic relationship between ocular immunoglobulin G4-related disease (IgG4-RD) and ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma 2014;55:1198–202.
   PubMed Web of Science ®Google Scholar
• Naresh KN, Barwick T, Karadimitris A. IgG4 positive mucosa associated lymphoid tissue lymphoma of the orbit-lesson of the month. Histopathology 2014;65:718–21.
   PubMed Web of Science ®Google Scholar
• Miki K, Orita Y, Sato Y, Sugitani I, Noyama M, Fuji S, et al. Mucosa-associated lymphoid tissue lymphoma of the thyroid with abundant IgG4-positive plasma cells. Auris Nasus Larynx 2013;40:587–90.
   PubMed Web of Science ®Google Scholar
• Venkataraman G, Rizzo KA, Chavez JJ, Streubel B, Raffeld M, Jaffe ES, et al. Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol 2011;24:355–66.
   PubMed Web of Science ®Google Scholar
• Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007;20:23–8.
   PubMed Web of Science ®Google Scholar
• Deshpande V, Chicano S, Finkelberg D, Selig MK, Mino-Kenudson M, Brugge WR, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2006;30:1537–45.
   PubMed Web of Science ®Google Scholar
• Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol 2011;64:237–43.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61:554–8.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: ARC Press; 2008.
   Google Scholar
• Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community. Arthritis Rheum 1993;36:340–7.
   PubMed Web of Science ®Google Scholar
• Baer AN, Gourin CG, Westra WH, Cox DP, Greenspan JS, Daniels TE. Rare diagnosis of IgG4-related systemic disease by lip biopsy in an international Sjögren syndrome registry. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115:e34–9.
   Web of Science ®Google Scholar
• Hermet M, Andre M, Kemeny JL, Le Guenno G, Dechelotte P, Guettrot-Imbert G, et al. Is IgG4-related disease a cause of xerostomia? a cohort study of 60 patients. Int J Rheumatol 2012;2012:303506.
   PubMedGoogle Scholar
• Mavragani CP, Fragoulis GE, Rontogianni D, Kanariou M, Moutsopoulos HM. Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease? Arthritis Care Res (Hoboken) 2014;66:773–7.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Yamamoto M, Tabeya T, Suzuki C, Naishiro Y, Shinomura Y, et al. The immunobiology and clinical characteristics of IgG4 related diseases. J Autoimmun 2012;39:93–6.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Yajima H, Takahashi H, Yokoyama Y, Ishigami K, Shimizu Y, et al. Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: results from the SMART database. Mod Rheumatol 2015;25:199–204.
   PubMed Web of Science ®Google Scholar
• Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 2015;94:e680.
   PubMed Web of Science ®Google Scholar
• Inoue D, Zen Y, Abo H, Gabata T, Demachi H, Kobayashi T, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology 2009;251:260–70.
   PubMed Web of Science ®Google Scholar
• Matsui S, Taki H, Shinoda K, Suzuki K, Hayashi R, Tobe K, et al. Respiratory involvement in IgG4-related Mikulicz's disease. Mod Rheumatol 2012;22:31–9.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009;58:1504–7.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Campochiaro C, Bozzolo EP, Dagna L, Scotti R, Nicoletti R, et al. Methotrexate for maintenance of remission in IgG4-related disease. Rheumatology (Oxford) 2015;54:1934–6.
   PubMed Web of Science ®Google Scholar
• Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czako L, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013;62:1771–6.
   PubMed Web of Science ®Google Scholar
• Kanda H, Koya J, Uozaki H, Tateishi S, Sato K, Hagino N, et al. Membranous nephropathy with repeated flares in IgG4-related disease. Clin Kidney J 2013;6:204–7.
   PubMedGoogle Scholar
• Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 2012;91:57–66.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 2015;74:1171–7.
   PubMed Web of Science ®Google Scholar
• Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 2015;67:1688–99.
   PubMed Web of Science ®Google Scholar
• Moriyama M, Tanaka A, Maehara T, Furukawa S, Nakashima H, Nakamura S. T helper subsets in Sjögren's syndrome and IgG4-related dacryoadenitis and sialoadenitis: a critical review. J Autoimmun 2014;51:81–8.
   PubMed Web of Science ®Google Scholar